Cargando…
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia
This study aimed to identify the factors associated with timely (within four weeks) HCV RNA testing and timely (within six months) DAA initiation following HCV notification in the DAA era. We conducted a cohort study of people with an HCV notification in NSW, Australia. Notifications of positive HCV...
Autores principales: | Yousafzai, Mohammad T., Alavi, Maryam, Valerio, Heather, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319806/ https://www.ncbi.nlm.nih.gov/pubmed/35891474 http://dx.doi.org/10.3390/v14071496 |
Ejemplares similares
-
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications
por: Kwon, Jisoo A., et al.
Publicado: (2021) -
Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014)
por: Waziry, Reem, et al.
Publicado: (2017) -
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study
por: Hosseini‐Hooshyar, Samira, et al.
Publicado: (2022) -
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales
por: Shah, Syed Hassan Bin Usman, et al.
Publicado: (2022) -
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012
por: Alavi, Maryam, et al.
Publicado: (2018)